EUVIMEDEUVIMED entdecken
Fallbericht

Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials

Rajeev Soman iD, Sanraksha Mayya, Geethu Joe

Microbial Drug Resistance · 01.08.2026 · 32 (8) · 321-324

DOI: 10.1177/10766294261448636 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Microbial Drug Resistance, online erschienen am 13.05.2026. Verfasst von Rajeev Soman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Jupiter Hospital, Pune, India. Hauptthemen laut MEDLINE: Fluoroquinolones, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newer methicillin-resistant antimicrobials are needed to address the rising prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative (MRCONS) infections. We describe two contrasting, recalcitrant staphylococcal infections successfully managed using early transition to the oral benzoquinolizine antibiotic alalevonadifloxacin, highlighting its utility in complex clinical settings. Two high-severity cases of staphylococcal infections are presented. Patient 1, a 58-year-old metastatic lung and orthopedic implant infection on hemodialysis, developed catheter-associated MRSA sepsis with bacteremia, endocarditis, and metastatic lung and orthopedic implant infection. Patient 2, a 41-year-old male with a prior craniotomy, presented with a chronic cranial wound infection due to methicillin-resistant Staphylococcus hominis (MRCONS) originating from an infected ex vivo bone flap. Both patients initially received intravenous therapy and were transitioned to oral alalevonadifloxacin upon availability of susceptibility data. Levonadifloxacin susceptibility testing showed an MIC of 2 µg/mL for MRSA and 0.047 µg/mL for MRCONS-SCV. Patient 1 received 7 weeks of oral therapy aligned with POET recommendation for endocarditis, while Patient 2 completed 8 weeks of oral therapy consistent with OVIVA-based management of osteomyelitis. Despite significant challenges, both patients demonstrated rapid clinical improvement, resolution of infection, and no relapse during follow-up. These cases support oral alalevonadifloxacin as an effective and safe step-down option for complex MRSA and MRCONS infections, including endocarditis, osteomyelitis and meningitis. Alalevonadifloxacin (prodrug of levonadifloxacin) offers a promising oral treatment option when conventional agents are not suitable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoroquinolonesAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansMaleMiddle AgedAdultAdministration, OralMicrobial Sensitivity TestsQuinolizines

Stichwörter der Autor:innen

MRSAOVIVAPOETlevonadifloxacin

Substanzen

FluoroquinolonesAnti-Bacterial AgentslevonadifloxacinQuinolizines

Autor:innen und Institutionen

  • Department of Infectious Diseases, Jupiter Hospital, Pune, India.

ORCID-Profile: Rajeev Soman

Zitieren

APA

Soman, R., Mayya, S., & Joe, G. (2026). Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials. Microbial Drug Resistance, 32(8), 321-324. https://doi.org/10.1177/10766294261448636

Vancouver

Soman R, Mayya S, Joe G. Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials. Microbial Drug Resistance. 2026;32(8):321-324. doi:10.1177/10766294261448636

BibTeX
@article{Soman2026,
  author = {Soman, Rajeev and Mayya, Sanraksha and Joe, Geethu},
  title = {Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials},
  journal = {Microbial Drug Resistance},
  year = {2026},
  volume = {32},
  number = {8},
  pages = {321--324},
  doi = {10.1177/10766294261448636}
}
Kostenlos starten →